In recent studies, a new subtype of SFRP2+ fibroblasts, SFRP2+PRSS23+ fibroblasts, and SFRP2+SFRP4+ myofibroblasts, a unique subtype of SSc fibroblasts, were identified. Here, SFRP2 is linked to systemic sclerosis.